Please login to the form below
Vaxigrip
This page shows the latest Vaxigrip news and features for those working in and with pharma, biotech and healthcare.
AZ wins EU approval for four-strain flu vaccine
Sanofi is still to have its four-strain vaccine recommended in the EU, however, although it was accepted for review by the EMA under the brand name Vaxigrip in April. ... The vaccine is also approved for the youngest patient population in Europe, as
Latest news
-
Sanofi’s four-strain flu vaccine Vaxigrip under review in EU
Pharma company also launches production of ingredient for malaria drug. Sanofi's four-strain (quadrivalent) influenza vaccine Vaxigrip has been accepted by the European Medicines Agency (EMA) for review for approval ... If approved, Vaxigrip will be
-
Sanofi has 65 new compounds in development, says R&D chief
hexavalent vaccine (DTP-Hep B-Polio-Hib), as well as a filing in the EU for Sanofi's quadrivalent flu vaccine Vaxigrip QIV.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
- Client Services Director- Flexible Working
-
Negotiable
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Events Executive
-
DOE
- Account Manager – Healthcare advertising
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary plus benefits
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- AbbVie/Allergan's merger faces public opposition
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Report: Customer experience, shaping digital healthcare
- The benefits of uniting in a divergent environment
- Encouraging signs in biomarker R&D
- J&J puts pressure on rivals with new Erleada okay in prostate cancer
- Pharma exhibition stand design with added value
- Bluebird Bio reveals further encouraging data for CALD gene therapy
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
